Literature DB >> 18939378

Current management of cystic neoplasms of the pancreas.

D R Carpizo1, P J Allen, M F Brennan.   

Abstract

Over the last decade there has been a dramatic increase in the number of patients identified with pancreatic cysts. This increase has been largely attributed to advances in imaging. The majority of these cysts represent benign neoplasms; however, a significant fraction of these are pre-malignant or malignant. Because the majority of these neoplasms are benign, many reports have advocated a selective approach to surgical resection. Here we review the literature that has contributed to the development of our approach to the management of these cystic neoplasms. We provide an overview of the key features in diagnosis and in predicting malignancy. Particular attention is given to the natural history and management of intraductal papillary mucinous neoplasms (IPMN).

Entities:  

Mesh:

Year:  2008        PMID: 18939378     DOI: 10.1016/s1479-666x(08)80055-8

Source DB:  PubMed          Journal:  Surgeon        ISSN: 1479-666X            Impact factor:   2.392


  8 in total

Review 1.  Does EUS-FNA molecular analysis carry additional value when compared to cytology in the diagnosis of pancreatic cystic neoplasm? A systematic review.

Authors:  Amy Gillis; Ilaria Cipollone; Grainne Cousins; Kevin Conlon
Journal:  HPB (Oxford)       Date:  2014-11-27       Impact factor: 3.647

2.  Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.

Authors:  Jian Wu; Yuchen Jiao; Marco Dal Molin; Anirban Maitra; Roeland F de Wilde; Laura D Wood; James R Eshleman; Michael G Goggins; Christopher L Wolfgang; Marcia I Canto; Richard D Schulick; Barish H Edil; Michael A Choti; Volkan Adsay; David S Klimstra; G Johan A Offerhaus; Alison P Klein; Levy Kopelovich; Hannah Carter; Rachel Karchin; Peter J Allen; C Max Schmidt; Yoshiki Naito; Luis A Diaz; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-08       Impact factor: 11.205

3.  Natural history of intraductal papillary mucinous neoplasia: How much do we really know?

Authors:  Chad G Ball; Thomas J Howard
Journal:  World J Gastrointest Surg       Date:  2010-10-27

Review 4.  The incidental cystic pancreas mass: a practical approach.

Authors:  Richard M Gore; Daniel R Wenzke; Kiran H Thakrar; Geraldine M Newmark; Uday K Mehta; Jonathan W Berlin
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

5.  Cystic lesions of the pancreas: Improved understanding, diagnostics and refined outcomes.

Authors:  Bhawna Sirohi; Shailesh V Shrikhande
Journal:  South Asian J Cancer       Date:  2013-07

6.  Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts: A retrospective cohort study.

Authors:  Ozlem Mutluay Soyer; Bulent Baran; Asli Ciftcibasi Ormeci; Davut Sahin; Suut Gokturk; Sami Evirgen; Rafet Basar; Pinar Firat; Filiz Akyuz; Kadir Demir; Fatih Besisik; Sabahattin Kaymakoglu; Cetin Karaca
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

7.  Mutational analysis of cytocentrifugation supernatant fluid from pancreatic solid mass lesions.

Authors:  Sydney D Finkelstein; Marluce Bibbo; Thomas E Kowalski; David E Loren; Ali A Siddiqui; Charalambos Solomides; Eric Ellsworth
Journal:  Diagn Cytopathol       Date:  2013-11-22       Impact factor: 1.582

8.  The added value of using mutational profiling in addition to cytology in diagnosing aggressive pancreaticobiliary disease: review of clinical cases at a single center.

Authors:  Nidhi Malhotra; Sara A Jackson; Lindsay L Freed; Mindi A Styn; Mary K Sidawy; Nadim G Haddad; Sydney D Finkelstein
Journal:  BMC Gastroenterol       Date:  2014-08-01       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.